Novo Nordisk's Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs
Novo Nordisk has launched a once-daily Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the U.S. According to reports, this development provides an alternative to injectable treatments, which have seen significant demand. The Wegovy pill aims to broaden access to GLP-1 weight-loss drugs, offering a new option for individuals seeking treatment.
Never miss a Web3 update
Join our Telegram channel to receive news in real-time, straight to your phone.